BASF Offers Cash for Norwegian Drug Maker

BASF SE, the world’s biggest chemical maker, agreed to pay 4.85 billion Norwegian kroner ($842 million) for Norway’s Pronova BioPharma ASA to expand in fatty acids used in health foods.

There's a Time to Bet on Deutsche Bank... But When?
44:19 - Frederick Lane, managing partner at Lane Generational of Raymond James, discusses the problems at Deutsche Bank, his current investment strategy, and the attractiveness of the U.S. equity market. He speaks on "Bloomberg Surveillance." (Source: Bloomberg)
  • Rebecca Minkoff's Fashionable Aproach to Luxury
  • Market Concerns: Perceived or Real?
  • A Question of Liquidity in European Banking